# A Study Comparing the Safety, Efficacy, and Diffusion of Letibotulinum Toxin A Versus Other Botulinum Toxin Products in Adults With Moderate-to-Severe Forehead Wrinkles

> **NCT07072806** · PHASE4 · COMPLETED · sponsor: **Yonsei University** · enrollment: 20 (actual)

## Conditions studied

- Forehead Rhytides

## Interventions

- **DRUG:** Letibotulinum toxin A
- **DRUG:** Prabotulinum toxin A
- **DRUG:** Onabotulinum toxin A

## Key facts

- **NCT ID:** NCT07072806
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-06-14
- **Primary completion:** 2022-08-26
- **Final completion:** 2022-09-07
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2025-07-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07072806

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07072806, "A Study Comparing the Safety, Efficacy, and Diffusion of Letibotulinum Toxin A Versus Other Botulinum Toxin Products in Adults With Moderate-to-Severe Forehead Wrinkles". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT07072806. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*